Your search for ‘Smart & Biggar’ returned 2,497 results

On February 8, 2018, the Federal Court of Appeal issued public reasons for its decision dismissing Teva's appeal relating to the damages and costs awarded against it for its infringement of Janssen's patent for levofloxacin ...

In a March 4, 2014 decision (H-D USA LLC et al v Jamal Berrada et al, 2014 FC 207), the Federal Court recognized that Harley-Davidson may sell its SCREAMIN’ EAGLE brand of clothing and collateral items in Canada in connection with its well known HARLEY-DAVIDSON trade-mark ..

The Government intends to publish final regulations as soon as possible following Royal Assent of the Cannabis Act.

These provisions will not come into force until October 23, 2018.

The Canadian Intellectual Property Office has released revised guidance on examination of medical use claims: PN 2015-01 "Revised Examination Practice Respecting Medical Uses".

Registration of a trademark carries with it certain advantages that can greatly assist a party when enforcing its rights and is typically recommended.

On April 9, 2014, the Québec Superior Court issued its long-awaited decision in the matter of the interpretation of Québec’s Charter of the French language (the "French Charter") and its interplay with trade-marks.

The Honourable Justice Campbell of the Federal Court of Canada has recently awarded default judgment to Twentieth Century Fox, including $10,500,000 in damages, against an individual who had copied and posted episodes of The Simpsons and Family Guy on the internet (Fox v Hernandez).

The Federal Court has granted in part Pharmascience's motion to strike out portions of Teva's statement of claim under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations

In this two-part series, we will discuss important strategies to consider before Canadian trademark law changes on June 17, 2019,

The Trade-marks Office has proposed significant amendments to the Trade-marks Regulations ("Regulations").

As we have reported in our June 20, 2014 IP Update, the Government of Canada has passed into law Bill C-31, which contains numerous significant amendments to Canada’s Trademarks Act.

The Federal Court has issued their Public Judgment and Reasons concerning the financial compensation to be paid as a result of earlier patent infringement and validity proceedings...

On March 8, 2017, the Competition Bureau released a bulletin for public consultation entitled "Information requests from private parties in proceedings for recovery of loss or damages".

On March 18, 2026, the federal Minister of Health announced the creation of the Pharmaceutical and Life Sciences Sector Task Force, a joint initiative led by Health Canada and Innovation...

On November 15, 2022, Health Canada released a new guidance document, "Guidance on clinical evidence requirements for medical devices."

The provisions relating to confidential third-party rebates will not come into force at the same time as the other provisions.

On June 3, 2020, a proposed class action was commenced against over 50 generic drug manufacturers.